STOCK TITAN

Corebridge Financial 6.375% Junior Subordinated Notes due 2064 (CRBD) Form 4 Filings

CRBD NYSE

Every Form 4 that Corebridge Financial, Inc. 6.375% Junior Subordinated Notes due 2064 (CRBD) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow CRBD and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CRBD filings page.

Rhea-AI Summary

Corebridge Financial, Inc. ten-percent owner Nippon Life Insurance Co. reported two direct purchases of common stock on October 23, 2026: 411,516 shares at a weighted average price of $33.7365 per share and 184,093 shares at a weighted average price of $34.4802 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026. The weighted averages reflect multiple trades in ranges of $33.19 to $34.18 and $34.19 to $35.08, respectively.

Rhea-AI Summary

Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 246,440 common shares on October 22, 2026, at a weighted average price of $35.1523 per share. The purchases were made at prices ranging from $34.62 to $35.55 under a Rule 10b5-1 plan adopted August 7, 2026. Nippon Life reported 130,667,106 shares following the purchase, including shares held by its wholly owned subsidiary that Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a ten-percent owner of Corebridge Financial, Inc. (CRBD), purchased 217,182 common shares on October 21, 2026, at a weighted average price of $35.3820 per share. The reported post-transaction position was 130,420,666 shares, including 33,271 shares held of record by its wholly owned subsidiary, Nissay Asset Management Corporation.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) ten-percent owner Nippon Life Insurance Co. purchased 193,357 common shares on October 20, 2026, at a weighted average price of $35.0106 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026. The reported post-purchase position was 130,203,484 shares, comprising 130,170,213 shares held of record by Nippon Life and 33,271 held of record by its wholly owned subsidiary, Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., identified as a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 162,024 shares on October 19, 2026, at a weighted average price of $34.5087 per share. The shares were purchased in multiple transactions at prices ranging from $34.25 to $34.95, inclusive, under a Rule 10b5-1 plan adopted August 7, 2026. After the purchase, the reported total was 130,010,127 shares, including 33,271 shares held of record by its wholly owned subsidiary Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a 10% owner of Corebridge Financial, Inc. (CRBD), purchased 347,195 common shares on October 16, 2026, at a weighted average price of $34.7141 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026; individual prices ranged from $34.31 to $35.07, inclusive.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) ten percent owner Nippon Life Insurance Co. purchased 510,873 common shares on October 15, 2026, across three reported tranches. The weighted average prices were $32.8031 for 122,762 shares, $33.5659 for 361,127 shares, and $34.3787 for 26,984 shares. The corresponding purchase-price ranges were $32.28–$33.27, $33.28–$34.27, and $34.28–$34.48, respectively. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) ten-percent owner Nippon Life Insurance Co. purchased 602,103 common shares on October 14, 2026, at a weighted average price of $34.0259 per share. The purchase was made pursuant to a Rule 10b5-1 plan adopted August 7, 2026. The reported post-transaction holding was 128,990,035 shares, including 33,271 shares held of record by its wholly owned subsidiary, Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co, a 10% owner of Corebridge Financial, Inc. (CRBD), purchased 253,776 common shares on October 13, 2026, at a weighted average price of $34.6839 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026, at prices ranging from $34.38 to $35.08. Nippon Life's reported holdings following the purchase were 128,387,932 shares.

Rhea-AI Summary

Corebridge Financial, Inc. ten percent owner Nippon Life Insurance Co. reported two direct purchases of common stock: 336,750 shares on October 9, 2026, at a weighted average of $34.0717 per share, and 143,190 shares on October 12, 2026, at a weighted average of $34.4902 per share.

Rhea-AI Summary

Nippon Life Insurance Co., a 10% owner of Corebridge Financial, Inc. (CRBD), purchased 261,198 shares on October 8, 2026, at a weighted average price of $34.2989 per share. The individual purchase prices ranged from $34.04 to $34.62, inclusive, and the purchases were made under a Rule 10b5-1 plan adopted on August 7, 2026. Nippon Life’s reported post-transaction position was 127,654,216 shares.

Rhea-AI Summary

Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 606,912 shares of common stock on October 7, 2026, at a weighted-average price of $34.4038 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026; trade prices ranged from $34.21 to $34.87 per share.

Nippon Life Insurance Co.'s reported post-transaction position was 127,393,018 shares, including 127,359,747 shares held of record by Nippon Life and 33,271 held of record by its wholly owned subsidiary, Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 116,345 common shares on October 6, 2026, at a weighted average price of $35.2323 per share under a Rule 10b5-1 plan adopted August 7, 2026. Individual purchase prices ranged from $34.94 to $35.57. Following the purchase, Nippon Life reported 126,786,106 shares.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reports that Nippon Life Insurance Co., a ten percent owner, purchased 65,711 common shares on October 5, 2026, at a weighted average price of $34.7529 per share. The purchases were made under a Rule 10b5-1 plan adopted on August 7, 2026; prices across multiple transactions ranged from $34.36 to $35.05, inclusive. Nippon Life reported 126,669,761 shares following the purchase, including 33,271 shares held by its wholly owned subsidiary Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a 10% owner of Corebridge Financial, Inc. (CRBD), purchased 187,155 shares of common stock on October 2, 2026, at a weighted average price of $34.2713 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026. After the purchase, Nippon Life reported beneficial ownership of 126,604,050 shares, including shares held by its wholly owned subsidiary, Nissay Asset Management Corporation.

Rhea-AI Summary

Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), reported two direct Common Stock purchases on October 1, 2026: 152,573 shares at a weighted average price of $32.7781 per share and 119,635 shares at $33.4469 per share. The purchases were made pursuant to a Rule 10b5-1 plan adopted on August 7, 2026. The weighted average prices reflect multiple transactions within respective ranges of $32.29 to $33.28 and $33.29 to $33.64, inclusive.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reports that ten percent owner Nippon Life Insurance Co. purchased 348,215 common shares on September 30, 2026, at a weighted average price of $33.6461 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026. Nippon Life reported 126,144,687 shares following the transaction, including shares held of record by its wholly owned subsidiary Nissay Asset Management Corporation.

Rhea-AI Summary

Corebridge Financial, Inc. ten-percent owner Nippon Life Insurance Co. purchased 216,818 shares of common stock on September 29, 2026, at a weighted average price of $33.6731 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026; individual purchase prices ranged from $33.44 to $33.98.

After the purchase, Nippon Life reported 125,796,472 shares, including 125,763,201 held of record by Nippon Life and 33,271 held of record by its wholly owned subsidiary, Nissay Asset Management Corporation, which Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a ten-percent owner of Corebridge Financial, Inc. (CRBD), made two direct purchases of common stock on September 28, 2026: 736,814 shares at a weighted-average price of $34.0962 per share and 68,968 shares at a weighted-average price of $34.7561 per share. Both purchases were made under a Rule 10b5-1 plan adopted on August 7, 2026.

Rhea-AI Summary

Corebridge Financial, Inc. reported that 10% owner Nippon Life Insurance Co. purchased 178,840 common shares on September 25, 2026, at a weighted average price of $34.5232 per share. The purchases were made under a Rule 10b5-1 plan adopted August 7, 2026; prices ranged from $34.13 to $34.93. Nippon Life’s reported position after the purchase was 124,773,872 shares, including 124,740,601 held of record by Nippon Life and 33,271 held of record by its wholly owned subsidiary, Nissay Asset Management Corporation, which Nippon may be deemed to beneficially own.

Rhea-AI Summary

Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 258,878 shares of common stock on September 24, 2026, at a weighted average price of $33.8532 per share. The purchases were made under a Rule 10b5-1 plan adopted on August 7, 2026. Following the purchase, Nippon Life reported a position of 124,595,032 shares, including shares held of record by its wholly owned subsidiary, Nissay Asset Management Corporation.

Rhea-AI Summary

Corebridge Financial, Inc. ten percent owner Nippon Life Insurance Co. purchased 219,273 shares of common stock on September 23, 2026, at a weighted average price of $34.134 per share. The purchases were made under a Rule 10b5-1 plan adopted on August 7, 2026; transaction prices ranged from $33.73 to $34.32, inclusive. Nippon Life reported a resulting position of 124,336,154 shares.

Rhea-AI Summary

Corebridge Financial, Inc. ten percent owner Nippon Life Insurance Co. reported two direct purchases of common stock on September 22, 2026: 296,668 shares at a weighted average price of $34.3091, and 200 shares at $34.9200. The 296,668-share purchase comprised multiple transactions priced from $33.89 to $34.86. Both purchases were made under a Rule 10b5-1 plan adopted by Nippon Life Insurance Co. on August 7, 2026.

Rhea-AI Summary

Nippon Life Insurance Co, a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 212,828 shares on September 21, 2026, at a weighted average price of $35.0797 per share. The purchases were effected pursuant to a Rule 10b5-1 plan adopted August 7, 2026; prices ranged from $34.83 to $35.47. Nippon Life’s reported position after the transactions was 123,820,013 shares, including 33,271 shares held by its wholly owned subsidiary Nissay Asset Management Corporation that Nippon Life may be deemed to beneficially own.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that major stockholder Nippon Life Insurance Co, a more than ten percent owner, purchased 131,333 shares of common stock on September 18, 2026, in an open-market transaction at a weighted average price of $34.8847 per share.

The purchase was effected pursuant to a Rule 10b5-1 plan adopted by Nippon Life Insurance Co on August 7, 2026. After this transaction, Nippon Life Insurance Co is reported as beneficially owning 123,607,185 shares in total, including 123,573,914 shares held directly and 33,271 shares held by its wholly owned subsidiary Nissay Asset Management Corporation.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that major shareholder Nippon Life Insurance Co purchased 174,760 shares of common stock on September 17, 2026 in an open-market or private transaction at a weighted average price of $35.20 per share, under a Rule 10b5-1 trading plan. Following this purchase, Nippon Life and its subsidiary together beneficially own 123,475,852 shares of Corebridge common stock.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that major shareholder NIPPON LIFE INSURANCE CO, a more-than-ten-percent owner, purchased 320,785 shares of Common Stock on September 16, 2026 at a weighted average price of $35.0171 per share in open-market transactions made pursuant to a Rule 10b5-1 plan adopted on August 7, 2026.

After these purchases, the reporting person is shown as beneficially owning 123,301,092 shares, including 123,267,821 shares held directly and 33,271 shares held by Nissay Asset Management Corporation, its direct wholly owned subsidiary, which it may be deemed to beneficially own; the reported price reflects multiple trades between $34.57 and $35.42 per share.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) had a large shareholder, Nippon Life Insurance Co., report the purchase of additional common stock. On September 15, 2026, Nippon Life bought 210,903 shares of Corebridge common stock at a weighted average price of $35.0199 per share, in multiple trades ranging from $34.76 to $35.38. After this purchase, Nippon Life reported beneficial ownership of 122,980,307 shares, including 122,947,036 shares held directly and 33,271 shares held by Nissay Asset Management Corporation, its wholly owned subsidiary, which Nippon Life may be deemed to beneficially own. The filing states that these purchases were made pursuant to a Rule 10b5-1 trading plan adopted on August 7, 2026.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that ten percent owner Nippon Life Insurance Co purchased 295,967 shares of common stock on September 14, 2026, in an open-market or private transaction at a weighted average price of $34.8642 per share. After this trade, Nippon Life is reported as directly holding 122,769,404 shares, including 33,271 shares held of record by its wholly owned subsidiary Nissay Asset Management Corporation, which it may be deemed to beneficially own. The purchase was effected under a Rule 10b5-1 plan adopted on August 7, 2026.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reports that major shareholder Nippon Life Insurance Co, a more than 10% owner, purchased 171,144 shares of common stock on September 11, 2026 at a weighted average price of $34.61 per share. After this purchase, Nippon Life is reported as beneficially owning 122,473,437 shares, including shares held by its wholly owned subsidiary Nissay Asset Management Corporation. The transaction was effected pursuant to a Rule 10b5-1 plan adopted on August 7, 2026.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reports that Chief Information Officer David Ditillo sold 8,736 shares of common stock on September 11, 2026 at $35.00 per share in an open-market or private transaction made under a Rule 10b5-1 trading plan. Following this sale, he directly holds 102,417 shares, including 40,342 restricted stock units, each representing a contingent right to receive one share of common stock.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that major shareholder Nippon Life Insurance Co, a more-than-10% owner, purchased 176,300 shares of common stock on September 10, 2026 in open-market transactions at a weighted average price of $34.0098 per share under a Rule 10b5-1 plan. Following these purchases, Nippon Life and its wholly owned subsidiary together beneficially own 122,302,293 shares of Corebridge common stock.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reports that major shareholder Nippon Life Insurance Co, a more than ten percent owner, purchased 136,466 shares of common stock on September 9, 2026 at a weighted average price of $33.78 per share pursuant to a Rule 10b5-1 plan.

Following this open-market purchase, Nippon Life Insurance Co is reported as beneficially owning 122,125,993 shares of Corebridge common stock, including shares held by its wholly owned subsidiary Nissay Asset Management Corporation.

Rhea-AI Summary

Corebridge Financial, Inc. reported disposition transactions in this Form 4 filing.

Corebridge Financial, Inc. (CRBD), reporting with respect to Carlyle Tactical Private Credit Fund, disclosed that on September 9, 2026, 400,000 Series D Mandatory Redeemable Preferred Shares held indirectly through its subsidiary American General Life Insurance Company (AGLIC) were redeemed by the issuer at $25.3315 per share, leaving no Series D shares held. Corebridge, through AGLIC and another indirect wholly owned subsidiary, continues to indirectly hold Series A, B, C, E, I, J and K Mandatory Redeemable Preferred Shares in amounts ranging from 320,000 to 960,000 shares.

Rhea-AI Summary

Corebridge Financial, Inc. (CRBD) reported that executive officer Elizabeth B. Cropper, EVP & Chief Human Resources Officer, sold 7,745 shares of common stock on 2026-08-19 in an open-market transaction. The weighted average sale price was $33.0567 per share, with prices ranging from $33.055 to $33.065. Following this sale, she directly holds 46,473 shares of common stock, including 37,484 restricted stock units, each representing a contingent right to receive one share of Corebridge common stock.

Rhea-AI Summary

Argon Holdco LLC and affiliated Blackstone entities reported a sale of 14,500,000 shares of Corebridge Financial, Inc. common stock on 2026-08-10 at $33.87 per share, held indirectly. After this transaction, they report 47,462,123 shares of indirect ownership. Certain reporting persons state they may be deemed to beneficially own these securities but disclaim beneficial ownership except to the extent of their pecuniary interest.

Rhea-AI Summary

Corebridge Financial, Inc. Chief Information Officer David Ditillo reported an options exercise and share sale. He exercised employee stock options for 3,914 shares of common stock at an exercise price of $20.30 per share, then sold 12,414 shares of common stock at $34.00 per share. Following the transaction, he held options covering 18,914 shares expiring in 2033 and his equity holdings include 40,342 restricted stock units. All transactions were effected pursuant to a Rule 10b5-1 trading plan.

Rhea-AI Summary

Corebridge Financial Chief Information Officer David Ditillo reported Rule 10b5-1 plan trades on 16 July 2026. He sold 12,414 common shares at $32.00 and exercised employee stock options for 3,914 shares at $20.30. Following these moves he holds 119,653 common shares, including 40,342 restricted stock units, and retains 22,828 options exercisable at $20.30 expiring in 2033.

Rhea-AI Summary

Corebridge Financial Chief Information Officer David Ditillo sold 4,250 shares of Common Stock in an open-market transaction at $30.00 per share. The sale occurred on July 6, 2026. After this trade, he directly holds 128,153 shares of the company’s stock.

This post-transaction position includes 40,342 restricted stock units, each representing a contingent right to receive one share of Corebridge common stock. The filing shows no derivative securities remaining in his reported holdings.

Rhea-AI Summary

Colberg Alan B. reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial director Alan B. Colberg reported an equity award of 6,553 deferred stock units (DSUs) of common stock. The DSUs were granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan at no cash price and are exempt under Rule 16b-3.

Following this grant, Colberg holds 64,962 shares in total, including 34,962 DSUs. Each DSU represents the right to receive one share of Corebridge common stock when his board service ends, linking a portion of his compensation to future company performance.

Rhea-AI Summary

Schioldager Amy L. reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial, Inc. director Amy L. Schioldager reported an equity compensation award in the form of deferred stock units (DSUs). She received 6,553 DSUs on common stock at a grant price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan.

Each DSU represents the right to receive one share of Corebridge common stock upon her termination of board service. Following this grant, her reported holdings total 34,962 DSUs, reflecting her accumulated director equity compensation in deferred form.

Rhea-AI Summary

Parris Colin J. reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial, Inc. director Colin J. Parris received a stock-based award in the form of deferred stock units (DSUs). On June 18, 2026, he was granted 6,553 DSUs at a stated price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan, exempt under Rule 16b-3. Each DSU represents the right to receive one share of Corebridge common stock when his board service ends. Following this grant, Parris holds a total of 13,894 DSUs, which track an equivalent number of common shares but generally do not settle until his termination of service.

Rhea-AI Summary

Lynch Christopher S. reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial, Inc. director Christopher S. Lynch received an award of 6,553 deferred stock units (DSUs) of common stock as a compensation grant. The DSUs were issued at no cash cost and increase his holdings to 34,962 DSUs, each convertible into one share when his board service ends.

Rhea-AI Summary

Corebridge Financial director Deborah R. Leone received an equity award rather than trading shares on the market. On this Form 4, she acquired 6,553 shares of common stock in the form of deferred stock units (DSUs) granted under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan at a grant price of $0.00 per share. After this grant, she holds 19,136 DSUs, each representing the right to receive one share of Corebridge common stock when her board service ends. This is a routine compensation-related award exempt under Rule 16b-3.

Rhea-AI Summary

Bousa Edward Peter reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial, Inc. director Edward Peter Bousa received an equity award of 6,553 deferred stock units on June 18, 2026. The award was granted at a price of $0.00 per unit under the Corebridge Financial, Inc. 2022 Omnibus Incentive Plan. Each DSU represents a right to receive one share of common stock upon his termination of service as a director. Following this grant, Bousa holds a total of 16,852 DSUs, reflecting his accumulated stock-based board compensation rather than an open-market share purchase.

Rhea-AI Summary

Gubbay Keith reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial director Keith Gubbay received an equity award in the form of deferred stock units. He was granted 6,553 deferred stock units (DSUs) of Corebridge Financial, Inc. common stock under the 2022 Omnibus Incentive Plan, increasing his holdings to 13,894 DSUs. Each DSU represents one share, deliverable when his board service ends, and the grant was made at no cash cost to him as a compensation award rather than an open-market purchase.

Rhea-AI Summary

Filiaggi Christopher reported acquisition or exercise transactions in this Form 4 filing.

Corebridge Financial, Inc. reported that Interim CFO and CAO Christopher Filiaggi received a grant of 30,549 shares of common stock on a restricted stock unit basis as a special retention equity award. The grant was approved by the Board’s Compensation and Management Development Committee.

The RSUs are time-vested and will cliff vest on April 1, 2028, meaning all units vest at once on that date, subject to his continued employment with the company through vesting. Following this award, Filiaggi directly holds 67,963 shares of common stock, which the disclosure notes includes 55,894 unvested RSUs. The award was granted under Corebridge’s 2022 Omnibus Incentive Plan and is described as exempt under Rule 16b-3.

Rhea-AI Summary

Corebridge Financial, Inc.’s Chief Financial Officer Elias F. Habayeb reported a tax-related share disposition tied to restricted stock units. On March 2, he disposed of 21,196 shares of common stock at a reference price of $25.84 per share to cover withholding taxes upon RSU vesting, rather than through an open-market sale. After this transaction, he directly held 263,453 common shares, which includes 90,705 unvested RSUs previously reported.

Rhea-AI Summary

Corebridge Financial executive Elizabeth B. Cropper, EVP & Chief Human Resources Officer, had 4,158 shares of common stock withheld on a Form 4 filing to cover taxes upon vesting of restricted stock units at $25.84 per share. After this tax-withholding disposition, she holds 54,218 shares directly, including 37,484 unvested RSUs.

Rhea-AI Summary

Corebridge Financial, Inc. Chief Operating Officer Christopher Brian Smith reported a tax-related share disposition tied to restricted stock units. On the reported date, 8,612 shares of common stock were withheld to cover taxes upon vesting of RSUs, using a reference price of $25.84 per share. After this tax-withholding transaction, he held 50,741 shares of common stock, including 28,804 unvested RSUs previously reported.